Remifentanil requirement for i-gel insertion is reduced in male patients with parkinson’s disease undergoing deep brain stimulator implantation:

HIGHLIGHTS

• who: Wenjun Meng from the Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China have published the paper: Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinsonu2019s disease undergoing deep brain stimulator implantation:, in the Journal: (JOURNAL) of 23/04/2019
• what: The aim of this study was to investigate whether the remifentanil requirement for facilitation of i-gel insertion in Parkinson`s disease (PD) patients undergoing deep brain stimulation (DBS) surgery was different from that in non . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.